Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)
Reference82 articles.
1. Montgomery S, Emir B, Haswell H, Prieto R. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability. Curr Med Res Opin. 2013;29:1223–30.
2. de Guglielmo G, Cippitelli A, Somaini L, Gerra G, Li H, Stopponi S, et al. Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat. Addict Biol. 2013;18:644–53.
3. Medstat.dk-National Institute for Health Data and Disease Control. Usage data on Lyrica. 2014. http://medstat.dk/en . Accessed 29 Nov 2014.
4. Pharma Marketing. Top 50 pharmaceutical products by global sales. 2015. http://www.pmlive.com/top_pharma_list/Top_50_pharmaceutical_products_by_global_sales . Accessed 28 Oct 2015.
5. Wettermark B, Brandt L, Kieler H, Boden R. Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment. Int J Clin Pract. 2014;68:104–10.
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献